<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Oral administration of <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> did not significantly alter the early stage of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0151773" disease_type="Disease or Syndrome" abbrv="">hypoplastic marrow</z:e> failure induced by <z:chebi fb="0" ids="28901">busulfan</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="17698">Chloramphenicol</z:chebi> reduction products were most suppressive to antigen-reactive cells detected by the Mishell-Dutton plaque-forming cell assay </plain></SENT>
<SENT sid="2" pm="."><plain>This reduction in immunocompetence may be an important parameter in the initial phases of the etiology of <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi>-induced <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>